Company: GEHC
Filing Date: 2025-06-05
Form Type: 424B2
Source: 0001193125-25-135863
Chunk: 4

Company: GE HealthCare Technologies Inc.
Filing Date: 2025-06-05
Form: 424B2
Chunk 4
---
 as well as our most recent Annual Report on Form 10-Kand Quarterly Report on Form 10-Q,which are incorporated by reference herein, completely and with the understanding that actual future results may be materially different from expectations. All forward-looking statements made in this prospectus, any accompanying prospectus supplement, and the documents incorporated or deemed to be incorporated by reference herein or therein are qualified by these cautionary statements. In particular, information included in this prospectus, any accompanying prospectus supplement, or the documents incorporated by reference into this prospectus under headings such as “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Business” contain forward-looking statements. Where, in any forward-looking statement, an expectation or belief as to future results or events is expressed, such expectation or belief is based on the current plans and expectations of our management and expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the expectation or belief will result or be achieved or accomplished. Any forward-looking statement speaks only as of the date on which it is made. Factors that could cause our actual results to differ materially from those described in our forward-looking statements include, but are not limited to:

| • |     | operating in highly competitive markets; |

| • |     | global geopolitical and economic instability, including as a result of changes in trade and tariff policy, the 
 conflict between Ukraine and Russia, and tensions in the Middle East;                                          |

| • |     | public health crises, epidemics, and pandemics, and their effects on our business; |

| • |     | changes in third-party and government reimbursement processes, rates, and contractual relationships, including 
 related to government shutdowns, and changes in the mix of public and private payers;                          |

| • |     | demand for our products, services, or solutions and factors that affect that demand; |

| • |     | developments in the market in China; |

| • |     | our ability to control increases in healthcare costs and any subsequent effect on demand for our products, 
 services, or solutions;                                                                                    |

| • |     | our ability to successfully complete strategic transactions; |

| • |     | the impacts related to our increasing focus on and investment in cloud, edge computing, artificial intelligence 
 (“AI”), and software offerings;                                                                                 |

| • |     | management of our supply chain and our ability to cost-effectively secure the materials we need to operate our 
 business;                                                                                                      |